Ειδήσεις: ONCOLOGY | PXAI

Version	Description	Date
8.42	[ADDED SOURCE REGISTRY LIST VIEW]	04/03/2026 16:19
8.41	[LOCALIZED INDEX.PHP MENU AND MODALS TO US ENGLISH]	04/03/2026 16:11
8.40	[TRANSLATED FRONTEND TO US ENGLISH]	04/03/2026 16:10
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:50
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:46
8.40	[REVERTED TO STANDARD TABLE LAYOUT (US ENGLISH)]	04/03/2026 15:40
8.39	[FIXED DB CONNECTION SCOPE IN SOURCES LOGIC]	04/03/2026 15:38
8.38	[TRANSLATED SOURCES VIEW TO US ENGLISH]	04/03/2026 15:01
8.37	[FULL FRONTEND TRANSLATION (MENU, FEED, COMMENTS, TTS) TO US ENGLISH.]	04/03/2026 14:58
8.67	[MANUAL OVERRIDE OF GREEK MENU ITEMS]	04/03/2026 13:36
8.66	[NGINX OPTIMIZED MENU FIX]	04/03/2026 13:33
8.65	[FIXED GREEK MENU ITEMS]	04/03/2026 13:32
8.60	[MENU & UI LOCALIZATION TO US ENGLISH]	04/03/2026 13:30
8.50	[FULL TRANSLATION TO US ENGLISH]	04/03/2026 13:27
9.75	[INJECTED EVENT FUSION_SUMMARY INTO FEED LOOPS TO DISPLAY AI TAGS CORRECTLY]	26/02/2026 14:44

25/03 10:30 statnews.com

STAT+: How an outsider crept into Eli Lilly’s top ranks — and plans to drive its business forward

outsider Eli Lilly Loxo Oncology business strategy biotech leadership

25/03 09:04 defenseworld.net

Kura Oncology, Inc. (NASDAQ:KURA) Receives Average Rating of “Moderate Buy” from Brokerages

Kura Oncology Moderate Buy analyst consensus price target Wall Street Zen Mizuho

25/03 08:57 timesnownews.com

Lung Cancer Myths Busted: What You Think You Know Could Delay Diagnosis

lung cancer myths diagnosis screening awareness stigma

25/03 08:06 defenseworld.net

Pyxis Oncology (NASDAQ:PYXS) Price Target Lowered to $8.00 at Stifel Nicolaus

Pyxis Oncology price target Stifel Nicolaus Wall Street Zen Stephens RBC

24/03 19:32 yahoo.com

Gilead acquires first TCE asset with $2.2bn Ouro Medicines buyout

Gilead Ouro Medicines acquisition targeted cancer therapy oncology $2.2 billion

24/03 13:32 investing.com

Karyopharm stock gains 10% on mixed Phase 3 trial data

Karyopharm Phase 3 trial stock gains mixed results oncology investor sentiment

24/03 06:00 arxiv.org

Deep reflective reasoning in interdependence constrained structured data extraction from clinical notes for digital health

deep reflective reasoning structured data extraction clinical notes LLM oncology interdependence

24/03 00:37 investing.com

Gilead to buy biotech firm Ouro Medicines in over $2 billion deal

Gilead Sciences Ouro Medicines acquisition biotech $2B oncology

23/03 18:47 investing.com

Celldex Therapeutics stock gains after analyst upgrade

Celldex Therapeutics stock gains analyst upgrade drug pipeline oncology investor confidence

23/03 18:47 investing.com

Celldex Therapeutics stock gains after analyst upgrade

Celldex Therapeutics stock gains analyst upgrade drug pipeline oncology investor confidence

Loading...